Literature DB >> 33630645

E-liquid purchase as a function of workplace restriction in the experimental tobacco marketplace.

Roberta Freitas-Lemos1, Jeffrey S Stein1, Derek A Pope1, Jeremiah Brown1, Marc Feinstein1, Kelsey M Stamborski1, Allison N Tegge1, Bryan W Heckman2, Warren K Bickel1.   

Abstract

E-cigarette use is prohibited in most smoke-free environments. The effect of this policy on tobacco consumption could be examined using the Experimental Tobacco Marketplace (ETM). The ETM allows observation of policy on smokers' purchasing behavior under conditions that simulate "real-world" circumstances. A within-subject design was used to evaluate the effect of workplace policy (Vaping Allowed vs. Not Allowed) and nicotine concentration (24 mg/mL vs. 0 mg/mL) on tobacco product consumption. Participants (n = 31) completed one sampling and two ETM/workplace sessions per week for 2 weeks. During the sampling session, participants were given an e-cigarette with a 2-day supply of a commercially available e-liquid of their preferred flavor. Before purchasing, participants were informed whether e-cigarette use was permitted. During the four ETM sessions, participants purchased for the following 24 hr, including the 4-hr work shift that started immediately after buying products in the ETM. The workplace session consisted of data entry tasks in a mock office environment. Participants could use any purchased tobacco products during two 15-min breaks. Condition order was counterbalanced. The results show that permitting E-cigarette use in the workplace increased e-liquid purchase on average, but nicotine concentration had no effect on e-liquid demand. Cigarette demand was unaltered across conditions. The present study suggests that allowing e-cigarette use in the workplace would increase demand for e-liquid regardless of nicotine strength. However, it would not change conventional cigarette demand. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33630645      PMCID: PMC8384943          DOI: 10.1037/pha0000444

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.492


  21 in total

1.  Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings.

Authors:  L S Cox; S T Tiffany; A G Christen
Journal:  Nicotine Tob Res       Date:  2001-02       Impact factor: 4.244

Review 2.  Electronic cigarette substitution in the experimental tobacco marketplace: A review.

Authors:  Warren K Bickel; Derek A Pope; Brent A Kaplan; William Brady DeHart; Mikhail N Koffarnus; Jeffrey S Stein
Journal:  Prev Med       Date:  2018-04-24       Impact factor: 4.018

3.  Nicotine gum as a substitute for cigarettes: a behavioral economic analysis.

Authors:  T A Shahan; A L Odum; W K Bickel
Journal:  Behav Pharmacol       Date:  2000-02       Impact factor: 2.293

4.  Attitudes and knowledge about nicotine and nicotine replacement therapy.

Authors:  Marc E Mooney; Adam M Leventhal; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2006-06       Impact factor: 4.244

5.  The R package beezdemand: Behavioral Economic Easy Demand.

Authors:  Brent A Kaplan; Shawn P Gilroy; Derek D Reed; Mikhail N Koffarnus; Steven R Hursh
Journal:  Perspect Behav Sci       Date:  2018-12-12

6.  Nicotine without smoke: fighting the tobacco epidemic with harm reduction.

Authors:  Robert Beaglehole; Clive Bates; Ben Youdan; Ruth Bonita
Journal:  Lancet       Date:  2019-08-31       Impact factor: 79.321

7.  Experimental tobacco marketplace: substitutability of e-cigarette liquid for cigarettes as a function of nicotine strength.

Authors:  Derek A Pope; Lindsey Poe; Jeffrey S Stein; Brent A Kaplan; Bryan W Heckman; Leonard H Epstein; Warren K Bickel
Journal:  Tob Control       Date:  2018-04-18       Impact factor: 7.552

8.  Characterizing use patterns and perceptions of relative harm in dual users of electronic and tobacco cigarettes.

Authors:  Olga Rass; Lauren R Pacek; Patrick S Johnson; Matthew W Johnson
Journal:  Exp Clin Psychopharmacol       Date:  2015-09-21       Impact factor: 3.157

9.  Smokers' use of nicotine replacement therapy for reasons other than stopping smoking: findings from the ITC Four Country Survey.

Authors:  David Hammond; Jessica L Reid; Pete Driezen; K Michael Cummings; Ron Borland; Geoffrey T Fong; Ann McNeill
Journal:  Addiction       Date:  2008-10       Impact factor: 6.526

10.  Estimating the harms of nicotine-containing products using the MCDA approach.

Authors:  David J Nutt; Lawrence D Phillips; David Balfour; H Valerie Curran; Martin Dockrell; Jonathan Foulds; Karl Fagerstrom; Kgosi Letlape; Anders Milton; Riccardo Polosa; John Ramsey; David Sweanor
Journal:  Eur Addict Res       Date:  2014-04-03       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.